Endocrine & Metabolic Agents
Formulations supporting the management of diabetes, thyroid disorders, metabolic conditions, and related endocrine health needs. Includes antidiabetic therapies, thyroid medications, and other agents designed to support metabolic and hormonal management.
17
Products (SKUs)
Who-GMP
Certified Facility
FDCA
(Gujarat) Approved
Export
Ready
| SR | PRODUCT NAME | DOSAGE FORM | PHARMACOLOGICAL SUB-CLASS |
|---|---|---|---|
| 1 | Empagliflozin Tablets 25 mg | Tablet | SGLT-2 Inhibitor (Antidiabetic) |
| 2 | Empagliflozin 10 mg Tablets | Tablet | SGLT-2 Inhibitor |
| 3 | Empagliflozin 12.5 mg & Metformin HCl 500 mg Tablets | Tablet (Combination) | SGLT-2 Inhibitor + Biguanide |
| 4 | Dapagliflozin Tablets 5 mg | Tablet | SGLT-2 Inhibitor |
| 5 | Dapagliflozin Tablets 10 mg | Tablet | SGLT-2 Inhibitor |
| 6 | Dapagliflozin Tablets 10 mg (Second Entry) | Tablet | SGLT-2 Inhibitor |
| 7 | Vildagliptin 50 mg & Metformin 1000 mg Tablets | Tablet (Combination) | DPP-4 Inhibitor + Biguanide |
| 8 | Gliclazide Modified Release Tablets 60 mg | Modified Release Tablet | Sulfonylurea (Antidiabetic) |
| 9 | Prednisolone Tablets 5 mg | Tablet | Corticosteroid |
| 10 | Prednisolone Tablets BP 5 mg | Tablet (BP) | Corticosteroid |
| 11 | Deflazacort Tablets 6 mg | Tablet | Corticosteroid (Oxazoline Derivative) |
| 12 | Dexamethasone Tablets BP 0.5 mg | Tablet (BP) | Corticosteroid |
| 13 | Eplerenone Tablets BP 25 mg | Tablet (BP) | Selective Aldosterone Antagonist |
| 14 | Eplerenone Tablets BP 50 mg | Tablet (BP) | Selective Aldosterone Antagonist |
| 15 | Furosemide Tablets USP 20 mg | Tablet (USP) | Loop Diuretic |
| 16 | Alpha Ketoanalogue & Essential Amino Acids Tablets | Tablet (Combination) | Renal Metabolic Agent (CKD) |
| 17 | Cilostazol Tablets USP 100 mg | Tablet (USP) | PDE3 Inhibitor / Antiplatelet / Vasodilator |